Evidence map›Paper›PMID 35209026›Full record

ArticleMolecules (Basel, Switzerland)2022

Near-Infrared Light Irradiation of Porphyrin-Modified Gold Nanoparticles Promotes Cancer-Cell-Specific Cytotoxicity.

Hiromi Kurokawa, Atsushi Taninaka, Toru Yoshitomi, Hidemi Shigekawa, Hirofumi Matsui

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hiromi KurokawaFaculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Atsushi TaninakaFaculty of Pure and Applied Sciences, University of Tsukuba, Tsukuba 305-8573, Japan.
Toru YoshitomiResearch Center for Functional Materials, National Institute for Materials Science, Tsukuba 305-0044, Japan.
Hidemi ShigekawaFaculty of Pure and Applied Sciences, University of Tsukuba, Tsukuba 305-8573, Japan.
Hirofumi MatsuiFaculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
University of Tsukuba · JPNational Institute for Materials Science · JPTakano Hospital · JP

Funding

Japan Core Research Evolutional Science and Technology JPMJCR1875Kaken Pharmaceutical (Japan) JP17H06088Kaken Pharmaceutical (Japan) JP19H02591Kaken Pharmaceutical (Japan) JP19K16854
6 · The paper itself

Abstract

The use of nanoparticles has been investigated as a new cancer treatment. These can induce specific cytotoxicity in cancer cells. In particular, Au nanoparticles (AuNPs) have unique characteristics. The maximum absorption spectrum of AuNPs can be adjusted to modify their size or shape to absorb near-infrared light that can penetrate into tissue without photodamage. Thus, the combination of AuNPs and near-infrared light can be used to treat cancer in deep-seated organs. To obtain effective cancer-specific accumulation of AuNPs, we focused on porphyrin and synthesized a porphyrin-attached Au compound: Au-HpD. In this study, we investigated whether Au-HpD possesses cancer-specific accumulation and cytotoxicity. Intracellular Au-HpD accumulation was higher in cancer cells than in normal cells. In order to analyze the cytotoxicity induced by Au-HpD, cancer cells and normal cells were co-cultured in the presence of Au-HpD; then, they were subjected to 870 nm laser irradiation. We observed that, after laser irradiation, cancer cells showed significant morphological changes, such as chromatin condensation and nuclear fragmentation indicative of cell apoptosis. This strong effect was not observed when normal cells were irradiated. Moreover, cancer cells underwent cell apoptosis with combination therapy.

Indexed as

GoldInfrared RaysMetal NanoparticlesPhototherapyPorphyrinsApoptosisCell Line, TumorHumansNeoplasmsGoldPorphyrinsAu-HpDnearinfraredphotodynamic therapyreactive oxygen species

Identifiers

PMID35209026
PMCPMC8879323
OpenAlexW4212837417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.